N-terminal pro-beta-type natriuretic peptide (NT-proBNP) can be considered a valuable predictor of heart rejection
- 9 September 2015
- journal article
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 31 (4) , 280-284
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Changes in serial B-type natriuretic peptide level independently predict cardiac allograft rejectionThe Journal of Heart and Lung Transplantation, 2012
- B-Type Natriuretic Peptide–Guided Heart Failure TherapyArchives of internal medicine (1960), 2010
- Clinical utility of NT-proBNP levels in late heart transplantation patientsClinica Chimica Acta, 2010
- Plasma Brain Natriuretic Peptide-Guided Therapy to Improve Outcome in Heart FailureJACC, 2007
- B-Type Natriuretic Peptide and the Risk of Cardiovascular Events and Death in Patients With Stable AnginaJACC, 2006
- How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic reviewBMJ, 2005
- Usefulness of N-terminal–pro-brain natriuretic peptide levels in predicting survival in heart transplant recipientsThe American Journal of Cardiology, 2004
- Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)Circulation, 2003
- B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart FailureCirculation, 2002